IMMUNOMODULATOR ACTIVITY OF MANGIFERIN FROM MANGO (MANGIFERA INDICA L.) IN CANCER: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.22159/ijpps.2021v13i10.42095Keywords:
Cancer, Immune, Mangiferin, Mango, LipoxigenaseAbstract
Cancer is a disease that is causing an increase in mortality all over the world. Cancer treatment is expensive and has a variety of side effects. Natural compound treatment is an attempt to reduce the side effects of cancer therapy. Mangiferin is a natural compound with anticancer and immunomodulatory activity. The immunomodulatory activity of mangiferin from mango (Mangifera indica L.) in cancer was discussed in this article.
The literature used in this review was obtained from several databases, including the Cochrane Library, Google Scholar, PubMed, ProQuest, ScienceDirect, and the Wiley Online Library, for articles published over the last ten years.
Mangiferin influenced anticancer activity by inhibiting NF-κB, affects the regulation of -catenin, EMT, MMP2, MMP9, LDH, NO, ROS, and inhibits classical macrophages activation.
Mangiferin has an immunomodulatory effect that can be developed as a candidate drug for anticancer therapy.
Downloads
References
Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, Jemal A. Cancer statistics for Hispanics/latinos, 2015. CA Cancer J Clin. 2015;65(6):457-80. doi: 10.3322/caac.21314, PMID 26375877.
Salehi B, Fokou PVT, Yamthe LRT, Tali BT, Adetunji CO, Rahavian A, Mudau FN, Martorell M, Setzer WN, Rodrigues CF, Martins N, Cho WC, Sharifi-Rad J. Phytochemicals in prostate cancer: from bioactive molecules to upcoming therapeutic agents. Nutrients. 2019;11(7):1-43. doi: 10.3390/nu11071483, PMID 31261861.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Issue Information. CA A Cancer J Clin. 2021;71(1):1-2. doi: 10.3322/caac.21617.
Fávaro WJ, Nunes OS, Seiva FRF, Nunes IS, Woolhiser LK, Durán N, Lenaerts AJ. Effects of P-MAPA immunomodulator on toll-like receptors and p53: potential therapeutic strategies for infectious diseases and cancer. Infect Agent Cancer. 2012;7(1):14. doi: 10.1186/1750-9378-7-14, PMID 22709446.
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebbé C, Ascierto PA, Long GV, Cebon J, Sosman J, Postow MA, Callahan MK, Walker D, Rollin L, Bhore R, Hodi FS, Larkin J. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377(14):1345-56. doi: 10.1056/NEJMoa1709684, PMID 28889792.
Jantan I, Ahmad W, Bukhari SNA. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015;6:655. doi: 10.3389/fpls.2015.00655, PMID 26379683.
Chang CY, Leu JD, Wang CY, Chen WR, Lee YJ. The combination of radiotherapy and immunotherapy using glycated chitosan as an immunological stimulant. Biophotonics Immune Resp 2015(9324):1-5.
Shang HS, Chen CJ, Shih YL, Peng SF, Chen YL, Liu KC, Huang HC, Hsueh SC, Chen KW, Lu HF, Lee MH, Lee MZ, Lu KW. Mangiferin induces immune responses and evaluates the survival rate in WEHI-3 cell generated mouse leukemia in vivo. Environ Toxicol. 2020;36:77-85. doi: 10.1002/tox.23013, PMID 32889744.
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86. doi: 10.1186/1476-4598-12-86, PMID 23915189.
Chen X, Song M, Zhang B, Zhang Y. Reactive oxygen species regulate t cell immune response in the tumor microenvironment. Oxid Med Cell Longev. 2016;2016:1580967. doi: 10.1155/2016/1580967. PMID 27547291.
Ahmadi M, King JW, Xue SA, Voisine C, Holler A, Wright GP, Waxman J, Morris E, Stauss HJ. CD3 limits the efficacy of TCR gene therapy in vivo. Blood. 2011;118(13):3528-37. doi: 10.1182/blood-2011-04-346338, PMID 21750319.
Meanwatthana J. Immune-related adverse events from immune checkpoint inhibitors: a review of risk factors in clinical practice. Pharm Sci Asia. 2020;47(2):104-12. doi: 10.29090/psa.2020.02.019.0095.
Piero NM, Joan NM. Cancer: A molecular curse. Int J Curr Pharm Res. 2015;7:1-3.
Lueangamornnara U U-pratya Y, Jiratchariyakul W, Kulprom A, O-charoenrat P, Kummalue T. Antiproliferative effects of three roots Thai herbal recipe on human cancer cell lines. Pharm Sci Asia. 2017;44:22-31.
Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Br J Cancer. 2014;110(2):341-52. doi: 10.1038/bjc.2013.752, PMID 24300974.
Kavitha M, Nataraj J, Essa MM, Memon MA, Manivasagam T. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson’s disease mice. Chem Biol Interact. 2013;206(2):239-47. doi: 10.1016/j.cbi.2013.09.016, PMID 24095822.
Song JH, Bae EY, Choi G, Hyun JW, Lee MY, Lee HW, Chae S. Protective effect of mango (Mangifera indica L.) against UVB-induced skin aging in hairless mice. Photodermatol Photoimmunol Photomed. 2013;29(2):84-9. doi: 10.1111/phpp.12030, PMID 23458392.
Ganneru S, Shaik H, Peddi K, Mudiam MKR. Evaluating the metabolic perturbations in Mangifera indica (mango) ripened with various ripening agents/practices through gas chromatography-mass spectrometry based metabolomics. J Sep Sci. 2019;42(19):3086-94. doi: 10.1002/jssc.201900291, PMID 31329331.
Zou B, Wang H, Liu Y, Qi P, Lei T, Sun M, Wang Y. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of notch3. Oncol Rep. 2017;38(3):1431-41. doi: 10.3892/or.2017.5814, PMID 28714011.
Du S, Liu H, Lei T, Xie X, Wang H, He X, Tong R, Wang Y. Mangiferin: an effective therapeutic agent against several disorders [review]. Mol Med Rep. 2018;18(6):4775-86. doi: 10.3892/mmr.2018.9529, PMID 30280187.
Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S, Tunon MJ. Fruit polyphenols, immunity and inflammation. Br J Nutr. 2010;104; Suppl 3:S15-27. doi: 10.1017/S0007114510003910, PMID 20955647.
Pandey PK, Ahmed B, Prasad J, Bala M, Khan HA. Radiomodifying action, pharmacokinetic and biodistribution of ethyl 3,4,5-trihydroxybenzoate-implication in development of radiomitigator. Sci Rep. 2019;9(1):18873. doi: 10.1038/s41598-019-55316-2, PMID 31827168.
Hewavitharana AK, Tan ZW, Shimada R, Shaw PN, Flanagan BM. Between fruit variability of the bioactive compounds, β-carotene and mangiferin, in mango ( Mangifera indica ). Nutr Diet. 2013;70(2):158-63. doi: 10.1111/1747-0080.12009.
Krishnananda KK, Shabaraya AR. Comparison of antibacterial activity of leaves extracts of (Tectona grandis), (Mangifera indica L.), and (Anacardium occidentale). Int J Curr Pharm Res. 2016;9:36-9.
Viswanadh EK, Rao BN, Rao BS. Antigenotoxic effect of mangiferin and changes in antioxidant enzyme levels of Swiss albino mice treated with cadmium chloride. Hum Exp Toxicol. 2010;29(5):409-18. doi: 10.1177/0960327110361752, PMID 20150354.
Noratto GD, Bertoldi MC, Krenek K, Talcott ST, Stringheta PC, Mertens-Talcott SU. Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties. J Agric Food Chem. 2010;58(7):4104-12. doi: 10.1021/jf903161g, PMID 20205391.
Louisa M, Soediro TM, Suyatna FD. In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells. Asian Pac J Cancer Prev. 2014;15(4):1639-42. doi: 10.7314/apjcp.2014.15.4.1639, PMID 24641381.
Bulugonda RK, Kumar KA, Gangappa D, Beeda H, Philip GH, Rao DM. Mangiferin from (Pueraria tuberosa) reduces inflammation via inactivation of NLRP3 inflammasome. Sci Rep 2017;7:1-14.
Saleh S, El-Maraghy N, Reda E, Barakat W. Modulation of diabetes and dyslipidemia in diabetic insulin-resistant rats by mangiferin: role of adiponectin and TNF-α. An Acad Bras Cienc. 2014;86(4):1935-48. doi: 10.1590/0001-3765201420140212, PMID 25590730.
Márquez L, García-Bueno B, Madrigal JLM, Leza JC. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr. 2012;51(6):729-39. doi: 10.1007/s00394-011-0252-x, PMID 21986672.
Franquesa M, Hoogduijn MJ, Bestard O, Grinyó JM. Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol. 2012;3:212. doi: 10.3389/fimmu.2012.00212, PMID 22833744.
Gavaraskar K, Dhulap S, Hirwani RR. Therapeutic and cosmetic applications of evodiamine and its derivatives--a patent review. Fitoterapia. 2015;106:22-35. doi: 10.1016/j.fitote.2015.07.019, PMID 26255828.
Khurana RK, Gaspar BL, Welsby G, Katare OP, Singh KK, Singh B. Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phosholipidic nano-mixed micellar systems. Drug Delivery Transl Res. 2018;8(3):617-32. doi: 10.1007/s13346-018-0498-4, PMID 29637488.
Tafani M, Pucci B, Russo A, Schito L, Pellegrini L, Perrone GA. Modulators of HIF-1α and NFκB in cancer treatment: is it a rational approach for controlling malignant progression. Front Pharmacol. 2013;4:1-12.
Hou J, Zheng D, Fung G, Deng H, Chen L, Liang J, Jiang Y, Hu Y. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats. Can J Physiol Pharmacol. 2016;94(3):332-40. doi: 10.1139/cjpp-2015-0073, PMID 26751764.
Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823-30. doi: 10.1158/2326-6066.CIR-14-0112, PMID 25187272.
du Plessis-Stoman D, du Preez JGH, van de Venter M. Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines. Afr J Tradit Complement Altern Med. 2011;8(2):177-84. doi: 10.4314/ajtcam.v8i2.63206, PMID 22238500.
Du M, Wen G, Jin J, Chen Y, Cao J, Xu A. Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway. Anticancer Drugs. 2018;29(2):167-75. doi: 10.1097/CAD.0000000000000583, PMID 29215373.
Sekiguchi Y, Mano H, Nakatani S, Shimizu J, Kataoka A, Ogura K, Kimira Y, Ebata M, Wada M. Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation. Mol Med Rep. 2017;16(2):1328–32. doi: 10.3892/mmr.2017.6752, PMID 28627701.
Zheng Z, Lin C, Wang S, Wang P, Xu W, Ma W, et al. Suppressive activities of mangiferin on human epithelial ovarian cancer. Phytomedicine. 2020;76:. 153267PMID 153267.
Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31(12):2714–36. doi: 10.1038/emboj.2012.150, PMID 22617422.
Cai Z, Cao Y, Luo Y, Hu H, Ling H. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance. Clin Chim Acta. 2018;483:156-63. doi: 10.1016/j.cca.2018.04.033, PMID 29709449.
Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, et al. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol. 2013;272(1):180-90. doi: 10.1016/j.taap.2013.05.011, PMID 23707762.
Jacob A, Jing J, Lee J, Schedin P, Gilbert SM, Peden AA, Junutula JR, Prekeris R. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci. 2013;126(20):4647-58. doi: 10.1242/jcs.126573, PMID 23902685.
Padma VV, Kalaiselvi P, Yuvaraj R, Rabeeth M. Mangiferin induces cell death against rhabdomyosarcoma through sustained oxidative stress. Integr Med Res. 2015;4(2):66-75. doi: 10.1016/j.imr.2014.09.006, PMID 28664112.
Kamm A, Przychodzen P, Kuban-Jankowska A, Jacewicz D, Dabrowska AM, Nussberger S, et al, Wozniak M, Gorska-Ponikowska M. Nitric oxide and its derivatives in the cancer battlefield. Nitric Oxide-Biol Chem. 2019;93:102-14. doi: 10.1016/j.niox.2019.09.005, PMID 31541733.
Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: Aa review. World J Surg Oncol. 2013;118:1–11. doi: 10.1186/1477-7819-11-118, PMID 23718886.
Aquilano K, Baldelli S, Cardaci S, Rotilio G, Ciriolo MR. Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells. J Cell Sci. 2011;124(7):1043-54. doi: 10.1242/jcs.077149, PMID 21363890.
Dubey M, Nagarkoti S, Awasthi D, Singh AK, Chandra T, Kumaravelu J, Barthwal MK, Dikshit M. Nitric oxide-mediated apoptosis of neutrophils through caspase-8 and caspase-3-dependent mechanism. Cell Death Dis. 2016;7(9):1–12e2348. doi: 10.1038/cddis.2016.248, PMID 27584786.
Liou GY, Storz P. Reactive oxygen species in cancer. Free Radical Res. 2010;44(5):479-96. doi: 10.3109/ 10715761003667554, PMID 20370557.
Yu L, Chen M, Zhang R, Jin Z. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial-mediated apoptosis and suppression of cancer cell migration and invasion. J BUON. 2019;24(4):1581-6. PMID 31646812.
Park KR, Bryers JD. Effect of macrophage classical (M1) activation on implant-adherent macrophage interactions with Staphylococcus epidermidis: a murine in vitro model system. J Biomed Mater Res A. 2012;100(8):2045-53. doi: 10.1002/jbm.a.34087, PMID 22581669.
Wei Z, Yan L, Chen Y, Bao C, Daeng J, Deng J. Mangiferin inhibits classical macrophage activation via downregulating interferon regulatory factor 5 expression. Mol Med Rep. 2016;14(2):1091-8. doi: 10.3892/mmr.2016.5352, PMID 27277156.
Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2019;106(2):345-58. doi: 10.1002/JLB.3RU1018-378RR, PMID 30576000.
Jarvis JN, Meintjes G, Bicanic T, Buffa V, Hogan L, Mo S, et al, Tomlinson G, Kropf P, Noursadeghi M, Harrison TS. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated Cryptococcal meningitis. PLoOS Pathog. 2015;11(4):1–18e1004754. doi: 10.1371/journal.ppat.1004754, PMID 25853653.
Huang Y, Gao J, Meng XM, Jiang GL, Yang YR, Li H, Liu J, Li J. Involvement of mitogen-activated protein kinase activation in cyclooxygenase-2 and transforming growth factor-β production in alveolar macrophage from chronic bronchitis rats. Immunopharmacol Immunotoxicol. 2011;33(4):645-51. doi: 10.3109/08923973.2011.557383, PMID 21428715.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Fitra Fauziah, Rezlie Bellatasie, Yachi Qurrata Ayuni Lubakisar
This work is licensed under a Creative Commons Attribution 4.0 International License.
